1.
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
by Voight, Benjamin F, PhD
The Lancet (British edition), 2012-08-11, Vol.380 (9841), p.572-580

2.
Effects of resveratrol supplementation on plasma lipids: a systematic review and meta‐analysis of randomized controlled trials
by Sahebkar, Amirhossein
Nutrition reviews, 2013-12, Vol.71 (12), p.822-835

3.
Coconut oil consumption and cardiovascular risk factors in humans
by Eyres, Laurence
Nutrition reviews, 2016-04, Vol.74 (4), p.267-280

4.
Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus
by Ronda, Nicoletta
Annals of the rheumatic diseases, 2014-03, Vol.73 (3), p.609-615

5.
Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk
by His, Mathilde
European journal of epidemiology, 2014-01-01, Vol.29 (2), p.119-132

6.
National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years an...
by Farzadfar, Farshad, MD
The Lancet (British edition), 2011, Vol.377 (9765), p.578-586

7.
Meta-analysis of the effect of β-glucan intake on blood cholesterol and glucose levels
by Tiwari, Uma, Ph.D
Nutrition (Burbank, Los Angeles County, Calif.), 2011, Vol.27 (10), p.1008-1016

8.
Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: A systematic review and meta-analysis
by Daryabeygi-Khotbehsara, Reza
Complementary therapies in medicine, 2017-12, Vol.35, p.6-13

9.
Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event
by Weinstock-Guttman, Bianca
Journal of neurology, neurosurgery and psychiatry, 2013-11, Vol.84 (11), p.1186-1191

10.
Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial
by Panahi, Yunes
Complementary therapies in medicine, 2017, Vol.33, p.1-5

11.
The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study
by Xu, Lin
Diabetologia, 2017-09-09, Vol.60 (11), p.2210-2220

12.
Total cholesterol and LDL levels decrease before rheumatoid arthritis
by Myasoedova, Elena
Annals of the rheumatic diseases, 2010-07, Vol.69 (7), p.1310-1314

13.
Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL) – A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib...
by Landray, Martin J
The American heart journal, 2017, Vol.187, p.182-190

14.
30-Year Trends in Serum Lipids Among United States Adults: Results from the National Health and Nutrition Examination Surveys II, III, and 1999–2006
by Cohen, Jerome D., MD
The American journal of cardiology, 2010, Vol.106 (7), p.969-975

15.
Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women’s Health Initiative calcium/vitamin D randomized trial
by Schnatz, Peter F
Menopause (New York, N.Y.), 2014-08, Vol.21 (8), p.823-833

16.
Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study
by Grosso, Giuseppe
European journal of nutrition, 2014-11-04, Vol.54 (7), p.1129-1137

17.
Mechanism of Action of Niacin
by Kamanna, Vaijinath S., PhD
The American journal of cardiology, 2008, Vol.101 (8), p.S20-S26

18.
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
by Giugliano, Robert P
The Lancet (British edition), 2017-10-28, Vol.390 (10106), p.1962-1971

19.
Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials)
by Mosca, Lori, MD, MPH, PhD
The American journal of cardiology, 2016, Vol.119 (3), p.397-403

20.
Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study
by Rossebø, Anne B., MD
The American journal of cardiology, 2007, Vol.99 (7), p.970-973
